re: Ann: QRxPharma Resubmits MOXDUO New Drug ... Being an eternal optomist and sometime collector I really am going to frame that announcement for posterity along with my first ever cheque from HI.
Right now the $1.00, imo puts QRX at the risk invited/risk adverse crossroads:
Risk invited: this is a 5 bagger + stock if success with FDA.
Risk adverse: get out while you still can.
And I'm definitely not selling.
